Search Results
New England CEPAC: Duchenne muscular dystrophy, Policy Roundtable
New England CEPAC: Duchenne muscular dystrophy, Voting Session
New England CEPAC: Duchenne Muscular Dystrophy, Evidence Presentation
New England CEPAC: Duchenne Muscular Dystrophy, Public Comments
New England CEPAC: Evidence Presentation, Spinal Muscular Atrophy
New England CEPAC: Hemophilia March 29, 2018 (Morning session)
Why ICER Threatens Patient Access to Life-Changing Treatments
[Webinar] DYSTANCE 51, a Phase 2/3 Clinical Trial of Investigational Suvodirsen in Duchenne
Listen to the Duchenne Muscular Dystrophy Data Presentation Call November 18, 2014
Midwest CEPAC: Cystic Fibrosis Evidence Presentation, May 17, 2018
Establishing Common Terminology to Advance Efforts in Duchenne Muscular Dystrophy Newborn Screening
ADI” Association Duchenne Israel
![[Webinar] DYSTANCE 51, a Phase 2/3 Clinical Trial of Investigational Suvodirsen in Duchenne](https://img.youtube.com/vi/8oHbm6iqIkg/hqdefault.jpg)
